Alzheimer’s Start-up Gets $1.49 Million from NIH
Collaboration between MED prof, husband Carmela and Menachem Abraham collaborated on a start-up to develop novel therapeutics for Alzheimer’s disease. Klogene Therapeutics, Inc., recently won a $1.49 million grant from the National Institutes of Health. Photo by Jackie Ricciardi. Carmela Abraham came home one day three years ago from her BU lab, where she has […]
CTE Investigators Launch $16 Million Study
A former football player describes brain disease symptoms and angst Tim Fox, the 62-year-old former New England Patriots safety, was describing to a room full of brain scientists at the Boston University School of Medicine (MED) the ferocious style of play that he’d been trained in from an early age, one that had led to […]
Unraveling Alzheimer’s Disease
Alzheimer’s disease is an epidemic. It attacks the brain’s nerve cells, causing memory loss, behavioral changes, confusion, and deterioration of language skills. It affects more than five million Americans 65 and older, and that is expected to increase to 13.8 million by 2050 unless science finds a treatment. Alzheimer’s and other forms of dementia are […]